This article has Open Peer Review reports available.
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course
- Daiki Ueno1, 2,
- Masahiro Yao1, 3,
- Ukihide Tateishi4,
- Ryogo Minamimoto4,
- Kazuhide Makiyama1,
- Narihiko Hayashi1,
- Futoshi Sano1,
- Takayuki Murakami1,
- Takeshi Kishida5,
- Takeshi Miura5,
- Kazuki Kobayashi6,
- Sumio Noguchi6,
- Ichiro Ikeda7,
- Yoshiharu Ohgo2,
- Tomio Inoue3, 4,
- Yoshinobu Kubota1, 5 and
- Noboru Nakaigawa1, 5Email author
© Ueno et al.; licensee BioMed Central Ltd. 2012
Received: 20 November 2011
Accepted: 2 May 2012
Published: 2 May 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|20 Nov 2011||Submitted||Original manuscript|
|6 Jan 2012||Reviewed||Reviewer Report - Adam Metwalli|
|17 Jan 2012||Reviewed||Reviewer Report - Mary Hart|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|3 Feb 2012||Author responded||Author comments - Noboru Nakaigawa|
|Resubmission - Version 3|
|3 Feb 2012||Submitted||Manuscript version 3|
|6 Feb 2012||Author responded||Author comments - Noboru Nakaigawa|
|Resubmission - Version 4|
|6 Feb 2012||Submitted||Manuscript version 4|
|2 May 2012||Editorially accepted|
|2 May 2012||Article published||10.1186/1471-2407-12-162|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.